@article{1963a6278dfa4435b91d88272afbc9df,
title = "Bypass Surgery Versus Endovascular Therapy in Chronic Hemodialysis Patients With CLI Due to Infrainguinal Disease",
author = "Yoshitaka Kumada and Hideki Ishii and Toru Aoyama and Daisuke Kamoi and Takashi Sakakibara and Norio Umemoto and Susumu Suzuki and Hiroshi Takahashi and Toyoaki Murohara",
note = "Funding Information: Please note: Dr. Ishii has received lecture fees from Astellas Pharma, AstraZeneca, Daiichi-Sankyo Pharma, and MSD. Dr. Murohara has received lecture fees from Bayer Pharmaceutical, Daiichi-Sankyo, Dainippon Sumitomo Pharma, Kowa, MSD, Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, Novartis Pharma, Pfizer Japan, Sanofi, and Takeda Pharmaceutical; and unrestricted research grants for the Department of Cardiology, Nagoya University Graduate School of Medicine, from Astellas Pharma, Daiichi-Sankyo, Dainippon Sumitomo Pharma, Kowa, MSD, Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, Novartis Pharma, Otsuka Pharma, Pfizer Japan, Sanofi, Takeda Pharmaceutical, and Teijin Pharma. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2016",
month = oct,
day = "4",
doi = "10.1016/j.jacc.2016.07.736",
language = "English",
volume = "68",
pages = "1601--1602",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "14",
}